Company intelligence / Profile preview

Rhia Ventures

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Rhia Ventures (through RH Capital) invests in early-stage startups advancing reproductive and maternal health, including new contraceptive modalities, diagnostics for ovarian cancer, and digital health innovations. Its portfolio companies are primarily preclinical to early commercial stage, focusing on innovation and equity in women’s health.[2][4][5][6][8]

Therapeutic areas: OncologyInfectious DiseasesWomen's Health
Modalities: Medical deviceDiagnosticDigital healthPharmaceutical
Industry: Investors

Partnerships

Bill and Melinda Gates Foundation (Women’s Health Innovation Council support)Organon (via Cirqle Biomedical licensing agreement)

Beyond the preview

Go deeper on Rhia Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rhia Ventures.

Explore the full profile